Jubilant Ingrevia’s Board of Directors approved the unaudited financial results for the quarter and half-year ended September 30, 2025. The company reported a profit before tax of ₹59.46 crore for the quarter. Basic earnings per share stood at ₹2.77. The Board’s decision occurred at a meeting held on October 27, 2025.
Financial Performance Highlights
Jubilant Ingrevia announced its unaudited standalone financial results, showcasing the performance for Q2 2026 (July-September). Key highlights include:
- Revenue from operations: ₹1054.18 crore
- Profit before tax: ₹59.46 crore
- Net Profit: ₹44.03 crore
- Basic EPS: ₹2.77
Segmental Performance
The standalone results detail revenue and profit contributions from different segments:
- Speciality Chemicals: Revenue of ₹476.13 crore
- Nutrition & Health Solutions: Revenue of ₹165.18 crore
- Chemical Intermediates: Revenue of ₹412.87 crore
Consolidated Financials Overview
The consolidated results provide a broader view of Jubilant Ingrevia’s financial standing. The revenue from operations reached ₹1120.73 crore. The consolidated profit before tax stood at ₹92.86 crore and a net profit of ₹69.47 crore was registered.
Key Financial Ratios
The company provided essential financial ratios reflecting its financial health. This included a debt service coverage ratio of 3.50 and an interest service coverage ratio of 7.95. The net worth of the company stood at ₹2509.47 crore.
Source: BSE